At Bay Biosciences, we provide high-quality clinical-grade Mantle Cell Lymphoma Samples, including Lymphoma Tissue Samples, FFPE tumor tissue blocks, Human Serum Samples, Plasma, Human PBMC Samples, and Human Blood Samples collected from patients diagnosed with mantle cell lymphoma.

Our high-quality biospecimens allow researchers to investigate disease biology, discover biomarkers, evaluate treatment response, and develop new therapeutic strategies for hematologic malignancies.

Understanding Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a rare subtype of non-Hodgkin lymphoma that develops from abnormal B lymphocytes located within the mantle zone of lymph nodes.

As one of several Blood Cancer Samples and Hematologic Cancer Samples studied in oncology research, MCL accounts for approximately 2-10% of all non-Hodgkin lymphoma cases.

Although mantle cell lymphoma can develop at any age, it most commonly affects adults between 60 and 70 years of age and occurs more frequently in men than women.

Unlike some slow-growing lymphomas, mantle cell lymphoma is generally considered an aggressive disease.

Many patients are diagnosed after the cancer has already spread to multiple lymph nodes, the bone marrow, spleen, gastrointestinal tract, or other organs.

One of the defining biological features of mantle cell lymphoma is the overexpression of cyclin D1, usually caused by a chromosomal translocation between chromosomes 11 and 14.

This molecular abnormality plays an important role in diagnosis and continues to be an active area of lymphoma research.

Mantle Cell Lymphoma Samples

Signs and Symptoms of Mantle Cell Lymphoma

Symptoms vary depending on the extent of the disease and the organs involved.

Because mantle cell lymphoma often spreads before diagnosis, patients may experience both localized and systemic symptoms.

Common symptoms include:

Causes and Risk Factors of Mantle Cell Lymphoma

The exact cause of mantle cell lymphoma remains unknown.

However, several factors have been associated with an increased risk of mantle cell lymphoma, including:

Firstly, increasing age is one of the strongest risk factors, with most patients diagnosed after the age of 60.

Secondly, sex influences disease occurrence, as mantle cell lymphoma is more common in males.

Finally, white people are also more likely to acquire the disease as compared to other races.

Diagnosis of Mantle Cell Lymphoma

The diagnosis of mantle cell lymphoma begins with a detailed medical history and physical examination.

Physicians combine laboratory testing, imaging studies, and tissue analysis to confirm the diagnosis and determine disease extent.

Diagnostic evaluation may include:

  • Lymph node biopsy
  • Bone marrow biopsy
  • Blood test
  • Lactate dehydrogenase (LDH) testing
  • Beta-2 microglobulin testing
  • CT scan
  • PET scan
  • Endoscopy or colonoscopy for gastrointestinal involvement
  • Fluorescence in situ hybridization (FISH) testing
  • Cytogenetic analysis

Staging of Mantle Cell Lymphoma

After diagnosing mantle cell lymphoma, doctors perform additional tests to determine how far the disease has spread throughout the body.

This process, known as staging, may include imaging scans, blood tests, and bone marrow or lymph node biopsies.

The stage helps healthcare providers evaluate the extent of the lymphoma and develop the most appropriate treatment strategy.

Mantle cell lymphoma is classified into four stages.

Stage 1 indicates that the lymphoma is confined to a single lymph node region.

Stage 2 means the cancer has spread to two or more lymph node regions, but all are located on the same side of the diaphragm.

In Stage 3, lymphoma is present in lymph node regions both above and below the diaphragm.

Stage 4 is the most advanced and indicates that the disease has spread beyond the lymph nodes to other organs or tissues, such as the bone marrow, liver, or gastrointestinal tract.

While staging provides valuable information about disease spread, treatment decisions also consider factors such as symptoms, overall health, and the biological characteristics of the lymphoma.

Treatment of Mantle Cell Lymphoma

Treatment depends on disease stage, overall health, symptoms, and prognostic risk. Some popular options include:

Researchers continue evaluating novel targeted therapies and combination treatment approaches to improve long-term outcomes for patients with mantle cell lymphoma.

The Role of Mantle Cell Lymphoma Samples in Research

High-quality patient-derived biospecimens are essential for advancing lymphoma research and precision medicine.

Firstly, researchers use Mantle Cell Lymphoma Samples to investigate disease biology, genetic alterations, and mechanisms of lymphoma progression.

Secondly, scientists analyze Lymphoma Tissue Samples to identify diagnostic biomarkers, evaluate cyclin D1 expression, and study molecular pathways involved in B-cell malignancies.

Thirdly, Human Serum Samples, Human PBMC Samples, and Human Blood Samples allow investigators to examine circulating biomarkers, immune responses, and treatment-related changes throughout disease progression.

Frequently Asked Questions

What are Mantle Cell Lymphoma Samples?

Mantle Cell Lymphoma Samples are patient-derived biospecimens that include tumor tissue, blood, serum, plasma, PBMCs, and associated clinical information used to support lymphoma research.

What are Lymphoma Tissue Samples used for?

Researchers use Lymphoma Tissue Samples for biomarker discovery, molecular profiling, pathology studies, genomic research, and evaluating new therapies.

Why are Human PBMC Samples important in mantle cell lymphoma research?

Human PBMC Samples allow researchers to study immune cell function, immune responses, circulating tumor cells, and treatment effects in patients with mantle cell lymphoma.

Is mantle cell lymphoma considered a blood cancer?

Yes. Mantle cell lymphoma is classified as both a non-Hodgkin lymphoma and a hematologic malignancy, making it one of several important Blood Cancer Samples used in oncology research.

Are samples collected ethically?

Yes. All biospecimens are collected under IRB-approved protocols with informed consent and complete donor de-identification.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we provide high-quality clinical-grade biospecimens that support oncology research worldwide, including:

Have any questions? Please feel free to reach out to us.